Teams at Mineralys Therapeutics, Inc.

Lead and scale FP&A for a public biopharma preparing for launch: manage budgeting, forecasting, variance analysis, Adaptive Planning administration, commercial finance analyses, management reporting, and build SOX-ready scalable FP&A processes while partnering with functional leaders.

Lead Mineralys's global tax function and strategy, owning ASC 740 tax provision, compliance, transfer pricing, indirect and international tax, R&D credits, audits, SOX controls, and tax planning to support commercialization and growth.

Lead brand and disease communications for pre-launch through commercialization of Lorundrostat. Develop brand strategy, media and congress plans, advocacy and ambassador programs, agency management, rapid-response monitoring, and cross-functional MLR/PRC governance to drive HCP, patient, advocacy, and media engagement.